Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomerase

3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomerase

US Patent 11518750 · Granted Dec 6, 2022

Estimated economic value: $177,980,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Agents that target telomerase reverse transcriptase (TERT) for treating cancer a2025
3-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitor2025
3-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitor2025
Substituted chromanes, analogs thereof, and methods of use and synthesis2025
Substituted chromanes, analogs thereof, and methods of use and synthesis2025
Substituted fused pyrrolo-diazepinones and uses thereof2025
Catalysts and methods for enantioselective conjugate addition of amines to unsat2023
Enantioselective cross dehydrogenative coupling reactions and compounds synthesi2023
Substituted chromanes, analogs thereof, and methods of use and synthesis2023
Substituted chromanes, analogs thereof, and methods of use and synthesis2023
Beta-carbolines as positive allosteric modulators of the human serotonin recepto2022
Substituted tetrahydropyranoindoles, derivatives thereof, and their methods of s2022